Back
Denali Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
DNLI
Denali Therapeutics
Last Price:
24.70
Seasonality Move:
7.97%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.62 | Sell |
| 20-day SMA: | 27.35 | Sell |
| 50-day SMA: | 27.95 | Sell |
| 200-day SMA: | 22.57 | Buy |
| 8-day EMA: | 25.54 | Sell |
| 20-day EMA: | 26.7 | Sell |
| 50-day EMA: | 26.88 | Sell |
| 200-day EMA: | 24.19 | Buy |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.77 | Sell |
| Relative Strength Index (14 RSI): | 38.85 | Sell |
| Chaikin Money Flow: | 742863 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.99 - 29.27) | Sell |
| Bollinger Bands (100): | (22.95 - 28.61) | Sell |
Denali Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 24.69 while DNLI 8-day simple moving average is 25.62, which is a Sell signal.
- The stock price of DNLI is 24.69 while Denali Therapeutics 20-day SMA is 27.35, which makes it a Sell.
- Denali Therapeutics 50-day simple moving average is 27.95 while DNLI share price is 24.69, making it a Sell technically.
- DNLI stock price is 24.69 and Denali Therapeutics 200-day simple moving average is 22.57, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
35
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a Sell
The current Denali Therapeutics [DNLI] share price is $24.69. The Score for DNLI is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
3.55B
Price in USD:
24.69
Share Volume:
830.26K
Denali Therapeutics 52-Week Range
52-Week High:
33.33
52-Week Low:
14.56
Sell
35
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?
The Denali Therapeutics stock price is 24.69 USD today. -
Will DNLI stock go up or go down?
Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Denali Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 24.69 while DNLI 8-day exponential moving average is 25.54, which is a Sell signal.
- The stock price of DNLI is 24.69 while Denali Therapeutics 20-day EMA is 26.70, which makes it a Sell.
- Denali Therapeutics 50-day exponential moving average is 26.88 while DNLI share price is 24.69, making it a Sell technically.
- DNLI stock price is 24.69 and Denali Therapeutics 200-day simple moving average is 24.19, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
- DNLI Moving Average Covergence Divergence (MACD) indicator is -0.77, suggesting Denali Therapeutics is a Sell
- Denali Therapeutics Relative Strength Index (RSI) is 38.85, which suggest Denali Therapeutics is oversold
- The Bollinger Bands (25) for Denali Therapeutics is (24.99 - 29.27), which suggest Denali Therapeutics is a Sell
- The Bollinger Bands (100) for Denali Therapeutics is (22.95 - 28.61), which suggest Denali Therapeutics is a Sell
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.